Welcome to Medications.com

Ahead of the Bell: Shire Shares Rise - Houston Chronicle

Vyvanse is key to Shire's future, as its current top drug, Adderall XR, will lose patent protection next year. Shares of the British drug maker rose $2.85, ...

http://www.chron.com/disp/story.m... | Posted: Tue Feb 19 09:09:16 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea